Dynavax

For Dynavax’s Heplisav-B vaccine, we faced a two-fold challenge: first, to elevate awareness of the severe consequences of hepatitis B, and second, to highlight the unique benefit of the 2-dose, 1-month vaccination schedule. To achieve this, we crafted messaging that resonated on a personal level, ensuring that the urgency of prevention was felt by diverse audiences. The creative approach delivered a clear, distinct signal for the Heplisav-B brand, setting it apart in a crowded marketplace and reinforcing its vital role in public health.

Role: Creative Direction  |  Agency: Publicis NY